Nasopharyngitis: FDA reporting patterns
182,289 FDA FAERS reports mention Nasopharyngitis. 81,436 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 21,066 reports
- Etanercept: 20,762 reports
- Methotrexate: 8,636 reports
- Tofacitinib: 8,217 reports
- Infliximab: 8,085 reports
- Secukinumab: 7,522 reports
- Tocilizumab: 7,195 reports
- Rituximab: 7,194 reports
- Dupilumab: 6,751 reports
- Abatacept: 6,735 reports
- Certolizumab Pegol: 5,980 reports
- Prednisone: 5,410 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.